Elevance Health Files 8-K

TL;DR

ELEVANCE HEALTH FILED AN 8-K ON 9/15 FOR AN EVENT ON 9/8 - DETAILS PENDING

AI Summary

Elevance Health, Inc. filed an 8-K on September 15, 2025, reporting an event that occurred on September 8, 2025. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items, with no specific financial figures or new material events detailed in the provided text.

Why It Matters

This 8-K filing from Elevance Health signals a regulatory update or disclosure, though the specific nature of the event on September 8, 2025, requires further examination of the full document.

Risk Assessment

Risk Level: low — The filing is a standard 8-K disclosure without immediate indication of significant negative events or financial impact.

Key Numbers

• 20250915 — Filing Date (Date the 8-K was officially submitted to the SEC.)
• 20250908 — Event Date (The earliest date of the event(s) being reported in the 8-K.)

Key Players & Entities

• Elevance Health, Inc. (company) — Registrant
• Indiana (jurisdiction) — State of incorporation
• Anthem, Inc. (company) — Former company name
• WELLPOINT, INC (company) — Former company name

FAQ

From the Filing

0001193125-25-203542.txt : 20250915 0001193125-25-203542.hdr.sgml : 20250915 20250915160510 ACCESSION NUMBER: 0001193125-25-203542 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20250908 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250915 DATE AS OF CHANGE: 20250915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 251314351 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 d79603d8k.htm 8-K 8-K false 0001156039 0001156039 2025-09-08 2025-09-08     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2025 ( September 8, 2025 )     Elevance Health, Inc. (Exact name of registrant as specified in its charter)       Indiana   001-16751   35-2145715 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 220 Virginia Avenue Indianapolis , IN 46204 (Address of principal executive offices) (Zip Code) (833) 401-1577 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ELV   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01 Other Events. The Notes Offering On September 15, 2025, Elevance Health, Inc. (the “Company”) closed its sale of $750 million aggregate principal amount of its 4.000% Notes due 2028 (the “2028 Notes”), $750 million aggregate principal amount of its 4.600% Notes due 2032 (the “2032 Notes”), $1,000 million aggregate principal amount of its 5.000% Notes due 2036 (the “2036 Notes”) and $500 million aggregate principal amount of its 5.700% Notes due 2055 (the “2055 Notes” and, to